Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Aclaris Therapeutics
(0H8T.LSE) Q4 2024
Earnings
0H8T.LSE
Nov 6
Confirmed
Q2 2024
Q3 2024
Q4 2024
-0.29
-0.19
-0.1
-0.01
Details
Expected EPS
-0.005714
Actual EPS
-0.11
Surprise EPS
-0.1
Surprise Percent
-1,825.1%
Description
Aclaris Therapeutics (0H8T.LSE) has reported earnings of -0.11 per share for Q4 2024.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login